Policy: NIH to balance sex in cell and animal studies
By J. Clayton, F. S. Collins. Nature, 2014
1,604 citations recorded by the source corpus.
Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/ceb6e04d2d91afef49b8ef3c1d1d68a5c915b418
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Public Health, Environmental and Occupational Health
In Reproductive Medicine
Citations in the corpus
- Is Man the Measure of All Things? A Social Cognitive Account of Androcentrism (2018, background): “The U.S. National Institute of Health (NIH) now requires the inclusion of female subjects in research studies (Clayton & Collins, 2014; NIH Revitalization Act of 1993), and in some countries, job advertisements must legally use gender-inclusive language (GIBG, 2004).”
- Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps (2019, background): “( 20 ) Ja pa n 3, 31 6/ 3, 61 1 50 (4 257 ) † N o As ia n Am on g 1, 93 5 pa tie nt s w ith N AF LD US , 0 .”
- Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019 (2019, background): “Explanation The species, strain, substrain, sex, weight, and age of animals are critical factors that can influence most experimental results [97-101].”
- Addressing bias in big data and AI for health care: A call for open science (2021, background): “26 Gender biases during the preclinical stages of drug development could alter how women react to newly developed drugs.”
- Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. (2016, background): “ongoing debate about the improvement of scientific validity and reproducibility, with the eventual goal to improve translation.(5) It is also a major aspect in optimizing daily patient care.”
- Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use (2016, background): “More recently, the NIH announced plans to require grant applicants to describe how they will balance of male and female cells and animals in preclinical studies, unless sex-specific inclusion is unwarranted [6].”